The RAAS and Aldosterone: How Hypertension Becomes Self-Perpetuating

Beyond the Blood Pressure Number

Hypertension is typically defined and managed numerically - a blood pressure above 130/80 mmHg is treated with medications to bring the numbers down. This approach is clinically valuable but incomplete. It treats the consequence while leaving the mechanism intact.

The mechanism - in a large proportion of hypertensive adults - is the Renin-Angiotensin-Aldosterone System (RAAS): a hormonal cascade evolved to regulate blood volume and pressure during states of salt deprivation and hemorrhage, but chronically overactivated in modern adults by dietary salt excess, stress hormones, obesity, and declining kidney function.

Understanding the RAAS explains why hypertension becomes self-perpetuating, why target organ damage continues even with blood pressure control, and why certain nutritional interventions are mechanistically rational for cardiovascular protection.

---

The RAAS Cascade: Architecture of the System

The RAAS is a multi-organ hormonal relay system:

Step 1: Renin Release from the Kidney

The juxtaglomerular (JG) cells of the kidney afferent arteriole are the pressure sensors of the RAAS. They release renin - a protease enzyme - in response to:

• Reduced renal perfusion pressure (low blood pressure, dehydration, renal artery stenosis)
• Low sodium delivery to the macula densa in the distal tubule
• β₁-adrenergic stimulation (sympathetic nervous system activation, stress, catecholamines)

Step 2: Angiotensin I Generation

Renin cleaves angiotensinogen (produced by the liver) into Angiotensin I (Ang I) - an inactive decapeptide.

Step 3: ACE Converts Ang I to Ang II

Angiotensin-Converting Enzyme (ACE) - expressed primarily on pulmonary endothelial cells - cleaves two amino acids from Ang I to produce Angiotensin II (Ang II): the primary effector hormone of the RAAS.

Step 4: Angiotensin II Actions

Ang II exerts its effects through two receptor subtypes:

AT1 Receptors (pro-hypertensive, pro-fibrotic):

• Vasoconstriction: Direct VSMC contraction → immediate BP elevation
• Aldosterone stimulation (adrenal zona glomerulosa)
• Sodium retention in the proximal tubule
• Sympathetic potentiation: Increases norepinephrine release from nerve terminals
• Oxidative stress: Activates NADPH oxidase → superoxide production → NO quenching → endothelial dysfunction
• Inflammation: Activates NF-κB → TNF-α, IL-6, MCP-1 → vascular inflammation and fibrosis
• VSMC proliferation and hypertrophy: Via MAP kinase signaling

AT2 Receptors (counter-regulatory):

• Vasodilation, anti-proliferative, anti-inflammatory - generally opposing AT1 actions
• Less abundant but increasingly recognized as protective

Step 5: Aldosterone - The Master Sodium Retainer

Ang II stimulates the adrenal cortex to secrete aldosterone, a mineralocorticoid that acts on the distal nephron and collecting duct:

• Upregulates ENaC (Epithelial Sodium Channels) → increased Na⁺ reabsorption
• Upregulates Na⁺/K⁺-ATPase → Na⁺ retention, K⁺ excretion
• Activates Sgk1 (Serum- and glucocorticoid-inducible kinase 1) → ENaC trafficking to the apical membrane

Net effect: increased extracellular volume → increased cardiac preload → elevated blood pressure.

---

The Self-Perpetuating Cycle of RAAS Overactivation

In acute hemodynamic disturbances (hemorrhage, dehydration), RAAS activation is appropriate and self-limiting - once blood volume and pressure are restored, renin release is suppressed.

In chronic hypertension, the feedback is broken:

1. Chronic sympathetic activation (stress, sleep apnea, sedentary lifestyle) continuously stimulates β₁ receptors on JG cells → persistent renin release
2. Obesity and visceral fat produce leptin and adipokines that directly stimulate renin secretion and reduce potassium, which independently activates aldosterone
3. Ang II-driven oxidative stress damages the same JG cells that should suppress renin → impaired negative feedback
4. Aldosterone-induced fibrosis stiffens the kidney microvasculature → impaired renal pressure sensing → inability to suppress renin appropriately
5. RAAS-induced arterial stiffness increases pulse wave velocity → reflected pressure waves augment systolic pressure → kidney perceives persistent low perfusion → continued renin stimulus

This cascade explains resistant hypertension - blood pressure that remains elevated despite three antihypertensive medications - which affects an estimated 10-15% of all hypertensive adults.

---

Aldosterone Excess Beyond Blood Pressure: The Fibrotic Consequences

Primary aldosteronism (autonomous aldosterone secretion, usually from an adrenal adenoma) is now recognized to affect approximately 5-10% of all hypertensive patients - far more common than previously believed. But aldosterone excess does not need to be primary (autonomous) to cause damage.

Elevated aldosterone - even within the "normal" range - exerts pro-fibrotic effects through the mineralocorticoid receptor (MR) in cardiac and renal tissue:

• Cardiac fibrosis: Aldosterone activates MR in cardiac fibroblasts → upregulates TGF-β → collagen I/III synthesis → myocardial fibrosis → diastolic dysfunction → HFpEF
• Renal fibrosis: MR activation in renal tubular cells and interstitial fibroblasts → progressive nephron loss
• Vascular fibrosis: MR in VSMC and perivascular fibroblasts → perivascular and adventitial fibrosis → arterial stiffness

These fibrotic consequences explain why patients with controlled blood pressure but chronic RAAS overactivation continue to develop end-organ damage - the mechanism is not hemodynamic pressure; it is direct aldosterone-MR-mediated fibrotic signaling.

---

RAAS and Nitric Oxide: A Zero-Sum Antagonism

Angiotensin II and nitric oxide are fundamentally antagonistic regulatory systems:

• Ang II → NADPH oxidase activation → superoxide production → NO quenching
• Reduced NO → impaired vasodilation → elevated vascular resistance
• Reduced NO → impaired anti-thrombotic endothelial function
• Ang II also phosphorylates eNOS at an inhibitory site (Thr-495), directly reducing NO synthesis

Conversely:

• NO → inhibits renin secretion from JG cells
• NO → inhibits AT1 receptor expression in smooth muscle
• NO → inhibits aldosterone secretion from adrenal cells

This bidirectional antagonism means that RAAS overactivation and endothelial dysfunction are mutually reinforcing: elevated Ang II causes endothelial dysfunction, and endothelial dysfunction (reduced NO) removes the brake on RAAS activity.

Supporting NO production through L-citrulline, dietary nitrates, and endothelial antioxidants is not merely a blood pressure intervention - it directly opposes the RAAS activation cycle at the hormonal level.

---

Potassium and Magnesium: The Dietary RAAS Modulators

Two minerals with direct RAAS modulation capacity are chronically deficient in modern diets:

Potassium

• Directly suppresses aldosterone secretion from the adrenal gland (inverse relationship with serum K⁺)
• Reduces ENaC activity in the distal nephron
• Stimulates Na⁺/K⁺-ATPase in endothelial cells → sodium efflux → reduced vascular smooth muscle tone
• The original DASH diet's blood pressure benefit is largely explained by its potassium content (4,700 mg/day)
• Typical Western diet provides ~2,300 mg/day - well below requirements

Magnesium

• Inhibits renin secretion from JG cells
• Reduces AT1 receptor responsiveness to Ang II
• Acts as a physiological calcium channel blocker in VSMC (relaxes vascular smooth muscle)
• Mg²⁺ deficiency independently activates the RAAS

---

Nutritional and Lifestyle Interventions Targeting RAAS

CircO2 supports the NO arm of this anti-RAAS strategy - directly opposing Ang II-mediated vasoconstriction and suppressing the renin-RAAS feedback through NO's inhibitory action on JG cell renin release.

---

Conclusion

The RAAS is not simply a blood pressure regulation system - it is a pro-fibrotic, pro-inflammatory, pro-oxidative hormonal program that, when chronically activated, drives structural damage to the heart, vasculature, and kidneys independent of blood pressure magnitude. Its chronic overactivation in modern adults is driven by dietary sodium excess, potassium and magnesium deficiency, sympathetic hyperactivation, and obesity.

Understanding the RAAS explains the self-perpetuating nature of hypertension and its end-organ consequences. Targeting this system nutritionally - through sodium restriction, potassium and magnesium repletion, nitric oxide support, and anti-inflammatory intervention - provides mechanistically rational cardiovascular protection that complements and may reduce the need for pharmacological RAAS blockade.

See also: arterial-stiffness-pulse-wave-velocity-vascular-aging and how-endothelial-dysfunction-silently-damages-your-cardiovascular-system.

---